Market watch: Upcoming market catalysts in Q4 2015.
BioMedTracker research analyst at Sagient Research Systems, 3655 Nobel Drive, San Diego, California 92122, USA.
Michael
M
Liu
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D002166:Camptothecin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D017277:Drug Approval; D004338:Drug Combinations; D015195:Drug Design; D006801:Humans; D013395:Sucrose / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D004338:Drug Combinations; C561644:mavrilimumab; D013395:Sucrose; C533411:ocrelizumab; C584112:irinotecan sucrosofate; D002166:Camptothecin